LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • May 4th, 2010 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
THIS LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into as of the Effective Date by and between RIGEL PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 1180 Veterans Boulevard, South San Francisco, CA 94080 (“Rigel”) and ASTRAZENECA AB, a Swedish corporation having its principal place of business at SE-151-85, Södertälje, Sweden (“AZ”). Rigel and AZ are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
